<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03739528</url>
  </required_header>
  <id_info>
    <org_study_id>LEVODESA_04-2017</org_study_id>
    <nct_id>NCT03739528</nct_id>
  </id_info>
  <brief_title>Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery</brief_title>
  <acronym>LEADER7</acronym>
  <official_title>An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NTC srl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NTC srl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the non-inferiority of the study treatment
      (combined levofloxacin + dexamethasone eye drops) followed by dexamethasone eye drops alone
      vs. standard treatment in the prevention and treatment of postoperative ocular inflammation
      and prevention of infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In clinical practice, topical treatment following cataract surgery is frequently administered
      using a combination between an antibiotic and a corticosteroid to promote patient adherence
      to therapy and to obtain both prevention of infection and treatment of post-surgical
      inflammation.

      The combination of tobramycin and dexamethasone is among the most widely used combinations,
      however, treatment duration and the need for tapering posology over several weeks may favour
      the development of bacterial resistance. The study treatment associating a broad-spectrum
      antibiotic with a highly effective corticosteroid that can be used for a short period of time
      (one week) is therefore of considerable interest.

      The aim of this study is to evaluate the non-inferiority of the study treatment, used for a
      limited period of time and followed by dexamethasone alone, compared to standard treatment in
      preventing and treating ocular inflammation and in preventing post-operative infection while
      limiting the emergence of antibiotic resistance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2018</start_date>
  <completion_date type="Actual">December 19, 2018</completion_date>
  <primary_completion_date type="Actual">December 19, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized, parallel-group study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients without signs of anterior chamber inflammation</measure>
    <time_frame>After 14 days of treatment</time_frame>
    <description>The proportion of patients without signs of anterior chamber inflammation (sum of cells and flare score = 0). The following non-inferiority hypotheses will be tested: H0 : πT - πS ≤ - Δ; H1 : πT - πS &gt; - Δ. Where πT and πS are the proportions of patients without signs of anterior chamber inflammation in the test and standard treatments, respectively, and the non-inferiority margin is Δ = 10%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of endophthalmitis</measure>
    <time_frame>After 3, 7 and 14 days of treatment</time_frame>
    <description>The proportion of diagnoses of endophthalmitis after administration of study treatment in the study will be assessed and reported. Diagnosis of endophthalmitis is based on clinical evaluation of signs and symptoms (such as swollen eyelids, ocular pain, conjunctival hyperemia, decreased visual acuity, opaque vitreous) through slit lamp examination, and microbiological tests on conjunctival or corneal swabs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients without signs of anterior ocular chamber inflammation</measure>
    <time_frame>After 3 and 7 days of treatment</time_frame>
    <description>The proportion of patients without signs of anterior chamber inflammation (sum of cells and flare score = 0). The following non-inferiority hypotheses will be tested: H0 : πT - πS ≤ - Δ; H1 : πT - πS &gt; - Δ. Where πT and πS are the proportions of patients without signs of anterior chamber inflammation in the test and standard treatments, respectively, and the non-inferiority margin is Δ = 10%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conjunctival hyperemia</measure>
    <time_frame>After 3, 7 and 14 days of treatment</time_frame>
    <description>Conjunctival hyperemia will be evaluated with slit lamp and results provided as a score as follows: 0 = absence of inflammation, 1 = mild inflammation (some vessels injected), 2 = moderate inflammation (diffuse injection of vessels, but individual vessels are still discernable) 3 = severe inflammation (intense injection of vessels, individual vessels not easily discernable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Ocular Symptoms Score (TOSS)</measure>
    <time_frame>After 3, 7 and 14 days of treatment</time_frame>
    <description>The TOSS is a patient-reported evaluation in the TOSS Questionnaire of 3 ocular symptoms: itching/burning, hyperemia of conjunctiva and tearing. Each symptom is given a score: 0 = none, 1 = mild, 2 = moderate, 3 = severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular pain/discomfort: 4-point scale</measure>
    <time_frame>After 3, 7 and 14 days of treatment</time_frame>
    <description>Overall ocular pain and discomfort will be evaluated by the subject on a 4-point scale (0 = absent, 1 = mild, 2 = moderate, 3 = severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue therapy</measure>
    <time_frame>After 3, 7 and 14 days of treatment</time_frame>
    <description>All rescue therapy used following cataract surgery is to be reported at all visits.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intraocular pressure (IOP)</measure>
    <time_frame>At the Screening Visit, day 4, day 8 and day 15</time_frame>
    <description>IOP is measured using a tonometer. IOP is measured as mmHg; normal intraocular pressures average between 12-22 mm Hg.</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual acuity</measure>
    <time_frame>Measured on Day 15</time_frame>
    <description>Decrease in visual acuity assessed as per local clinical practice</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>From screening to Day 15</time_frame>
    <description>Adverse events will be described according to System Organ Classes (SOC) and Preferred Terms (PT) using the Medical Dictionary for Regulatory Activities (MedDRA) and will be presented by treatment group.</description>
  </other_outcome>
  <other_outcome>
    <measure>Global evaluation</measure>
    <time_frame>At day 4, day 8 and day 15</time_frame>
    <description>Global evaluation will be evaluated on a 4-point scale: 0 = no intolerability, 1 = mild intolerability, 2 = moderate intolerability, 3 = maximum intolerability.</description>
  </other_outcome>
  <other_outcome>
    <measure>Burning, stinging, blurred vision</measure>
    <time_frame>At day 4, day 8 and day 15</time_frame>
    <description>Burning, stinging, blurred vision will be evaluated on a 4-point scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe.</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of patient diary (compliance)</measure>
    <time_frame>At day 4, day 8 and day 15</time_frame>
    <description>Compliance will be evaluated on Day 4, Day 8 and Day 15 by means of a patient diary in which the instillations are to be recorded.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">808</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Levofloxacin + Dexamethasone followed by dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Levofloxacin 5 mg/ml+Dexamethasone 1 mg/ml (7 days,1 drop/4 times a day) followed by dexamethasone 1 mg/ml (7 days,1 drop/4 times a day).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tobramycin + dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tobramycin + dexamethasone (14 days, 1 drop/4 times a day).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levofloxacin + dexamethasone followed by dexamethasone</intervention_name>
    <description>Levofloxacin + dexamethasone ophthalmic solution for 7 days, 1 drop - 4 times a day, followed by dexamethasone ophthalmic suspension (Maxidex®) for an additional 7 days, 1 drop - 4 times a day.</description>
    <arm_group_label>Levofloxacin + Dexamethasone followed by dexamethasone</arm_group_label>
    <other_name>Levofloxacin + dexamethasone followed by Maxidex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tobramycin + Dexamethasone</intervention_name>
    <description>Tobramycin + dexamethasone ophthalmic suspension (Tobradex®) for 14 days, 1 drop - 4 times a day.</description>
    <arm_group_label>Tobramycin + dexamethasone</arm_group_label>
    <other_name>Tobradex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria prior to surgery:

          1. Signed written informed consent

          2. Male or female, age ≥40 years

          3. Scheduled senile or presenile cataract surgery

          4. Willing to interrupt the use of contact lenses for the entire duration of the study

          5. Able and willing to follow study procedures

          6. Female patients must be postmenopausal, surgically sterile or must agree to use an
             effective method of contraception

             Inclusion criteria following surgery:

          7. Surgery completed without complications

        Exclusion Criteria:

          1. Ocular conditions that at the discretion of the Investigator may interfere with the
             efficacy and/or safety evaluations

          2. Patients undergoing bilateral cataract surgery

          3. Patients under treatment with prostaglandin analogues or intravitreal injections of
             anti-vascular endothelial growth factor (VEGF) drugs

          4. Systemic diseases that may interfere with the results of the study

          5. Any condition that could interfere with correct instillation of eye drops

          6. Ocular surgery in the study eye (including laser surgery) in the 3 months before
             screening

          7. Monocular patients

          8. Visual Acuity &lt; 20/80 of the contralateral eye measured as ETDRS or Snellen

          9. Contraindications to ocular treatment with Tobradex®, Maxidex® or
             levofloxacin/dexamethasone

         10. Hypersensitivity to the study product or its excipients

         11. Participation in other clinical studies within at least 5 half-lives of the
             Investigational Medicinal Product (IMP) used in the previous studies

         12. Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Bandello, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Raffaele IRCCS S.r.l.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>A.O.U. Osp. Riuniti Umberto I - G.M. Lancisi - G. Salesi - Università degli Studi di Ancona</name>
      <address>
        <city>Ancona</city>
        <state>AN</state>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale della Murgia &quot;Fabio Perinei&quot; di Altamura</name>
      <address>
        <city>Altamura</city>
        <state>BA</state>
        <zip>70022</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Consorziale di Bari</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <zip>70125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASL Bari - Ospedale &quot;Di Venere&quot; - Carbonara di Bari</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <zip>70131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cliniche Gavazzeni S.p.A. - Humanitas Gavazzeni di Bergamo</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <zip>24125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. di Bologna - Policlinico S. Orsola-Malpighi di Bologna</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola-Malpighi di Bologna</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST degli Spedali Civili di Brescia - P.O. Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Franciacorta - P.O. di Chiari</name>
      <address>
        <city>Chiari</city>
        <state>BS</state>
        <zip>25032</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>P.O. Ospedale Clinicizzato SS. Annunziata di Chieti</name>
      <address>
        <city>Chieti</city>
        <state>CH</state>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Valduce di Como</name>
      <address>
        <city>Como</city>
        <state>CO</state>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Vittorio Emanuele - P.O. Gaspare Rodolico - Università degli Studi di Catania</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico G.B. Morgagni di Catania - Casa di Cura s.r.l.</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. Mater Domini di Catanzaro - Università degli Studi Magna Graecia di Catanzaro</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Casa Sollievo della Sofferenza di San Giovanni Rotondo</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>FG</state>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Careggi di Firenze</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Policlinico San Martino di Genova</name>
      <address>
        <city>Genova</city>
        <state>GE</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Policlinico San Martino - Università degli Studi di Genova</name>
      <address>
        <city>Genova</city>
        <state>GE</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fatebenefratelli - Ospedale &quot;Sacra Famiglia&quot; di Erba</name>
      <address>
        <city>Erba</city>
        <state>LC</state>
        <zip>22036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. USL Toscana Nord Ovest - Ospedale della Versilia</name>
      <address>
        <city>Lido Di Camaiore</city>
        <state>LU</state>
        <zip>55049</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AUSL Toscana Nord Ovest - P.O. San Luca di Lucca</name>
      <address>
        <city>San Filippo</city>
        <state>LU</state>
        <zip>56123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico &quot;G. Martino&quot; di Messina</name>
      <address>
        <city>Messina</city>
        <state>ME</state>
        <zip>98124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASP di Messina - P.O. &quot;Giuseppe Fogliani&quot; di Milazzo</name>
      <address>
        <city>Milazzo</city>
        <state>ME</state>
        <zip>98057</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Ovest Milanese - Ospedale Civile di Legnano</name>
      <address>
        <city>Legnano</city>
        <state>MI</state>
        <zip>20025</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gruppo Multimedica - Ospedale San Giuseppe di Milano</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele IRCCS S.r.l.</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Fatebenefratelli Sacco - Università degli Studi di Milano - Ospedale L. Sacco</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Clinico Humanitas di Rozzano</name>
      <address>
        <city>Rozzano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST di Melegnano e della Martesana - Ospedale di Vizzolo Predabissi</name>
      <address>
        <city>Vizzolo Predabissi</city>
        <state>MI</state>
        <zip>20077</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico di Modena - Università degli Studi di Modena e Reggio Emilia</name>
      <address>
        <city>Modena</city>
        <state>MO</state>
        <zip>41125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Sassuolo</name>
      <address>
        <city>Sassuolo</city>
        <state>MO</state>
        <zip>41049</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Polispecialistico Monterosso di Carrara</name>
      <address>
        <city>Carrara</city>
        <state>MS</state>
        <zip>54033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico &quot;P. Giaccone&quot; di Palermo</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. &quot;Ospedali Riuniti Villa Sofia-Cervello&quot; di Palermo - P.O. &quot;Villa Sofia&quot; di Palermo</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AUSL di Piacenza - Ospedale &quot;Guglielmo da Saliceto&quot; di Piacenza</name>
      <address>
        <city>Piacenza</city>
        <state>PC</state>
        <zip>Piacenza</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. ULSS 6 Euganea - Ospedali Riuniti Padova Sud - Ospedale Madre Teresa di Calcutta-Schiavonia</name>
      <address>
        <city>Monselice</city>
        <state>PD)</state>
        <zip>35043</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. ULSS 6 Euganea - Ospedale S. Antonio - Centro Oculistico San Paolo di Padova</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. di Perugia - Ospedale S. Maria della Misericordia di Perugia</name>
      <address>
        <city>Perugia</city>
        <state>PG</state>
        <zip>06156</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico S. Matteo - Università degli Studi di Pavia</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli di Reggio Calabria</name>
      <address>
        <city>Reggio Calabria</city>
        <state>RC</state>
        <zip>89124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Campus Bio-medico di Roma</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione PTV Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Sant'Andrea di Roma</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Fondazione G.B. Bietti di Roma</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00198</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASL Roma 4 - Ospedale San Paolo di Civitavecchia</name>
      <address>
        <city>Civitavecchia</city>
        <state>RN</state>
        <zip>00053</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. ULSS 5 Polesana - Ospedale &quot;Santa Maria della Misericordia&quot;</name>
      <address>
        <city>Rovigo</city>
        <state>RO</state>
        <zip>45100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U Città della Salute e della Scienza di Torino - Ospedale Molinette</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. Sanitaria Universitaria Integrata di Trieste - Ospedali Riuniti di Trieste - Ospedale Maggiore</name>
      <address>
        <city>Trieste</city>
        <state>TS</state>
        <zip>34129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. ULSS 2 Marca Trevigiana - Ospedale di Treviso</name>
      <address>
        <city>Treviso</city>
        <state>TV</state>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. Sanitaria Universitaria Integrata di Udine - P.O. Universitario &quot;Santa Maria della Misericordia&quot; diUdine</name>
      <address>
        <city>Udine</city>
        <state>UD</state>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. ULSS 7 Pedemontana - Ospedale San Bassiano di Bassano del Grappa</name>
      <address>
        <city>Bassano Del Grappa</city>
        <state>VI</state>
        <zip>36061</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sacro Cuore - Don Calabria di Negrar</name>
      <address>
        <city>Negrar</city>
        <state>VR</state>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Integrata di Verona - Ospedale Borgo Roma</name>
      <address>
        <city>Verona</city>
        <state>VR</state>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Az. Osp. di Rilievo Nazionale &quot;A. Cardarelli&quot; di Napoli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. &quot;Maggiore della Carità&quot; di Novara</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Senese - Università degli Studi di Siena</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>November 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>June 7, 2019</last_update_submitted>
  <last_update_submitted_qc>June 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levofloxacin</mesh_term>
    <mesh_term>Ofloxacin</mesh_term>
    <mesh_term>Tobramycin</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 12, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03739528/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <pending_results>
    <submitted>May 29, 2020</submitted>
    <returned>June 15, 2020</returned>
    <submitted>June 26, 2020</submitted>
    <returned>July 17, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

